Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

Feb 8, 2016 09:30 AM Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction
Feb 2, 2016 06:45 AM PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2015 RESULTS
Feb 1, 2016 06:55 AM Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan
Jan 21, 2016 09:05 AM Philogen Announces Exercise of Options Within the License Agreement With Pfizer Inc. for the Development and Potential Commercialization of Multiple Antibody Drug Conjugates (ADCs) and Targeted Techno
Jan 19, 2016 08:30 AM ViiV Healthcare & the Los Angeles Department of Health Services Announce New Fellowship Program to Address a Growing Shortage of Primary Care HIV Specialists
Jan 13, 2016 07:04 PM Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma
Jan 13, 2016 01:10 PM Calibr Enters Strategic Collaboration with Pfizer (PFE)
Jan 11, 2016 08:32 AM ChapStick® Announces Actress Rachel Bilson as New Brand Spokesperson
Jan 11, 2016 07:00 AM HemoShear Therapeutics Announces Next Stage of Safety Collaboration with Pfizer Inc.
Jan 8, 2016 04:13 PM Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations
Jan 8, 2016 08:00 AM Pfizer Enters into Translational Research Collaboration with Adaptive Biotechnologies to Help Advance Novel Immuno-Oncology Solutions
Jan 7, 2016 08:31 AM ViiV Healthcare to Progress Collaboration with Janssen to Develop the First Long-acting, Two Drug Injectable Regimen for Treatment of HIV-1 Infection
Jan 5, 2016 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer and Allergan Discussion at 34th Annual J.P. Morgan Healthcare Conference
Jan 4, 2016 08:00 AM Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer
Jan 4, 2016 06:00 AM KineMed Enters Into Strategic Proteomic Biomarker Discovery Collaboration with Pfizer Inc.
Dec 22, 2015 10:00 AM Pfizer Invites Public To View And Listen To Webcast Of February 2 Conference Call With Analysts
Dec 22, 2015 08:00 AM Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab
Dec 21, 2015 04:00 PM Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder
Dec 15, 2015 08:00 AM Alliance for Clinical Trials in Oncology and GNS Healthcare Launch Big Data Initiative to Transform Metastatic Colorectal Cancer Treatment
Dec 14, 2015 04:30 PM Pfizer Declares First-Quarter 2016 Dividend
Dec 14, 2015 10:30 AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Dec 10, 2015 04:15 PM AMPLIFY Post-Hoc Early Time Course Analysis Evaluated Recurrent Venous Thromboembolism (VTE), VTE-Related Death and Major Bleeding in Deep Vein Thrombosis and Pulmonary Embolism Patients Treated with
Dec 10, 2015 08:00 AM Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer
Dec 9, 2015 04:01 PM Spark Therapeutics Announces $15 Million Milestone Payment From Pfizer for Progress in Hemophilia B Gene Therapy Program
Dec 9, 2015 11:00 AM Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers
Dec 8, 2015 11:01 AM Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung
Dec 8, 2015 08:00 AM Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015
Dec 7, 2015 09:00 PM BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics
Dec 1, 2015 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Nov 30, 2015 05:11 AM Sosei Subsidiary Heptares Enters Strategic Drug Discovery Collaboration with Pfizer Inc. Focused on GPCR Targets Across Multiple Therapeutic Areas
Nov 30, 2015 05:00 AM Heptares Enters Strategic Drug Discovery Collaboration with Pfizer Inc. Focused on GPCR Targets Across Multiple Therapeutic Areas
Nov 30, 2015 02:00 AM PureTech Names Scientific Advisory Board and Expands Senior Team
Nov 25, 2015 08:00 AM Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA® (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain
Nov 25, 2015 04:00 AM Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products
Nov 25, 2015 02:00 AM Pfizer Receives European Approval to Expand Use of XALKORI® (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer
Nov 23, 2015 05:22 PM Fitch Places Allergan's Ratings on Positive Watch Following Pfizer Merger Announcement
Nov 23, 2015 07:03 AM Pfizer and Allergan to Combine
Nov 19, 2015 02:00 AM Servier Exercises Exclusive Worldwide Licensing Option with Cellectis for UCART19, an Allogeneic CAR-T Cell Therapy for Hematological Malignancies
Nov 18, 2015 08:00 AM Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI® (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung C
Nov 18, 2015 07:00 AM Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Nov 16, 2015 04:00 AM Global Partners Announce Donation of 500 Millionth Dose of Azithromycin, Marking Exceptional Progress to Help Alleviate the Suffering from Trachoma
Nov 6, 2015 04:15 PM Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the American Heart Association (AHA) Scientific Sessions 2015
Nov 5, 2015 08:00 AM Pfizer Expands its Patient Assistance Program, Doubling the Income Eligibility Limit to Benefit Even More Patients Taking Pfizer Medicines 
Nov 5, 2015 07:00 AM Global Analysis Of Metastatic Breast Cancer Landscape Reveals Gaps In Patient Care And Support
Nov 4, 2015 08:00 AM Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer
Nov 4, 2015 08:00 AM Merck and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer
Nov 3, 2015 08:24 AM ViiV Healthcare Announces Positive Headline Results from a Study of Two Drug Injectable Regimen for HIV Maintenance Therapy
Nov 2, 2015 08:06 AM New Data Continue to Characterize the Safety and Efficacy of XELJANZ® (tofacitinib citrate) in the Treatment of Rheumatoid Arthritis
Oct 30, 2015 10:27 PM Pfizer Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Relevant Securities in Issue
Oct 29, 2015 10:09 AM Pfizer Announcement Regarding Allergan plc

Back to PFE Stock Lookup